DE60234467D1 - Molekulare eigenschaften von nichtkleinzelligem lungenkrebs - Google Patents

Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Info

Publication number
DE60234467D1
DE60234467D1 DE60234467T DE60234467T DE60234467D1 DE 60234467 D1 DE60234467 D1 DE 60234467D1 DE 60234467 T DE60234467 T DE 60234467T DE 60234467 T DE60234467 T DE 60234467T DE 60234467 D1 DE60234467 D1 DE 60234467D1
Authority
DE
Germany
Prior art keywords
sage
small cell
gene expression
lung cancer
cell lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234467T
Other languages
English (en)
Inventor
Mariana Nacht
Tatiana Dracheva
David The John Hopki Sidransky
Stephen L Madden
Jin Jen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Genzyme Corp
Johns Hopkins University
School of Medicine of Johns Hopkins University
Original Assignee
US Department of Health and Human Services
Genzyme Corp
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Genzyme Corp, Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE60234467D1 publication Critical patent/DE60234467D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60234467T 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs Expired - Lifetime DE60234467D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31240001P 2001-08-16 2001-08-16
PCT/US2002/026027 WO2003015613A2 (en) 2001-08-16 2002-08-16 Molecular characteristics of non-small cell lung cancer

Publications (1)

Publication Number Publication Date
DE60234467D1 true DE60234467D1 (de) 2009-12-31

Family

ID=23211260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234467T Expired - Lifetime DE60234467D1 (de) 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Country Status (8)

Country Link
US (2) US7332590B2 (de)
EP (1) EP1453977B1 (de)
JP (1) JP2005503145A (de)
AT (1) ATE449187T1 (de)
AU (1) AU2002355963A1 (de)
CA (1) CA2456334A1 (de)
DE (1) DE60234467D1 (de)
WO (1) WO2003015613A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015613A2 (en) * 2001-08-16 2003-02-27 The United States Of America As Represented By The Secretrary Of Health And Human Services Molecular characteristics of non-small cell lung cancer
ATE331044T1 (de) * 2003-03-04 2006-07-15 Pamgene Bv Verfahren zur integrierten integritätsbewertung und analyse von nukleinsäuren
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
BRPI0410634A (pt) * 2003-05-30 2006-06-13 Astrazeneca Uk Ltd processo
CA3084542A1 (en) * 2003-06-10 2005-01-06 The Trustees Of Boston University Gene expression analysis of airway epithelial cells for diagnosing lung cancer
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
WO2005032495A2 (en) * 2003-10-03 2005-04-14 Bayer Pharmaceuticals Corporation Gene expression profiles and methods of use
JP4938451B2 (ja) 2004-03-23 2012-05-23 オンコセラピー・サイエンス株式会社 非小細胞肺癌の診断のための方法
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2006056080A1 (en) * 2004-11-29 2006-06-01 Diagnocure Inc. Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
US7504225B2 (en) 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
KR100710462B1 (ko) 2005-08-24 2007-04-24 광주과학기술원 폐암 진단용 퍼옥시레독신-ｉ자가항체 마커 및 이를 이용한진단키트
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
EP1999472A2 (de) 2006-03-09 2008-12-10 The Trustees Of Boston University Diagnose- und prognoseverfahren für lungenerkrankungen mittels genexpressionsprofilen aus nasenepithelzellen
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
EA010352B1 (ru) * 2006-10-09 2008-08-29 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Способ дифференциального анализа протеомов
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
CN101990577A (zh) 2007-09-19 2011-03-23 波士顿大学理事会 鉴定肺病药物开发的新途径
JP5583117B2 (ja) * 2008-05-14 2014-09-03 ユニバーシティー ヘルス ネットワーク 非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー
EP2145964A1 (de) * 2008-07-17 2010-01-20 Universität Zu Köln Verfahren zur Früherkennung und Prognose von Lungenkrebs
EP2315629B1 (de) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Tröpfchenbibliotheken
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
JP2012519290A (ja) 2009-03-04 2012-08-23 エフ．ホフマン−ラ ロシュ アーゲー 肺の扁平上皮癌のためのマーカーとしてのセルピンｂ１３
EP2411148B1 (de) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation von mikrofluidiktröpfchen
EP2486409A1 (de) 2009-10-09 2012-08-15 Universite De Strasbourg Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
EP2493916B1 (de) * 2009-10-26 2016-06-08 Externautics S.p.A. Marker für lungentumore und deren verwendung
EP2498778A1 (de) 2009-11-13 2012-09-19 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Diazeniumdiolatverbindungen, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US8535889B2 (en) 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP3447155A1 (de) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwichassays in tröpfchen
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (de) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzymquantifizierung
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
EP3626308A1 (de) 2013-03-14 2020-03-25 Veracyte, Inc. Verfahren zur bewertung eines copd-status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US20150087728A1 (en) * 2013-09-20 2015-03-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US9594085B2 (en) 2014-02-03 2017-03-14 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
WO2016073768A1 (en) 2014-11-05 2016-05-12 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
CN105154542B (zh) * 2015-09-01 2018-04-17 杭州源清生物科技有限公司 一组用于肺癌分子分型的基因及其应用
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
JP2022527972A (ja) * 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445990A (en) * 1981-11-12 1984-05-01 General Electric Company Electrolytic reactor for cleaning wastewater
US5763165A (en) * 1994-03-10 1998-06-09 Ludwig Institute For Cancer Research Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
CA2323833A1 (en) * 1998-03-31 1999-10-07 Genzyme Corporation Compositions and methods for the identification of lung tumor cells
EP1082459A4 (de) 1998-05-21 2002-09-25 Diadexus Inc Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer
WO2003015613A2 (en) * 2001-08-16 2003-02-27 The United States Of America As Represented By The Secretrary Of Health And Human Services Molecular characteristics of non-small cell lung cancer
US20060151337A1 (en) * 2005-01-07 2006-07-13 Gilmore F W Electrocoagulation Reaction Chamber

Also Published As

Publication number Publication date
CA2456334A1 (en) 2003-02-27
EP1453977A2 (de) 2004-09-08
EP1453977B1 (de) 2009-11-18
US20090270265A1 (en) 2009-10-29
US20050136403A1 (en) 2005-06-23
JP2005503145A (ja) 2005-02-03
US7332590B2 (en) 2008-02-19
WO2003015613A3 (en) 2004-06-24
WO2003015613A2 (en) 2003-02-27
ATE449187T1 (de) 2009-12-15
EP1453977A4 (de) 2005-04-20
AU2002355963A1 (en) 2003-03-03
US7709202B2 (en) 2010-05-04

Similar Documents

Publication Publication Date Title
DE60234467D1 (de) Molekulare eigenschaften von nichtkleinzelligem lungenkrebs
Ramos et al. Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer
Yanagisawa et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer
Anglani et al. Loss of connectivity in cancer co-expression networks
Bittner et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling
Deeb et al. Machine learning-based classification of diffuse large B-cell lymphoma patients by their protein expression profiles
Ferlizza et al. The roadmap of colorectal cancer screening
Dao et al. Inferring cancer subnetwork markers using density-constrained biclustering
US7247426B2 (en) Classifying cancers
MX2007006441A (es) Prognosis de cancer de pulmon.
Giuliani et al. Epigenetic variability across human populations: a focus on DNA methylation profiles of the KRTCAP3, MAD1L1 and BRSK2 genes
Al-Ruwaili et al. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis
Herold et al. Biosensors and molecular technologies for cancer diagnostics
CN109444425A (zh) 一种细胞水平蛋白高通量检测方法
Adam et al. The recurring features of molecular subtypes in distinct gastrointestinal malignancies—A systematic review
Menyailo et al. Heterogeneity of Circulating Epithelial Cells in Breast Cancer at Single‐Cell Resolution: Identifying Tumor and Hybrid Cells
Poornima et al. Genomic alphabets of saliva as a biomarker in oral cancer
Rao et al. Laser capture microdissection: a gear for pancreatic cancer research
Becker et al. Clinical proteomics: new trends for protein microarrays
Maxwell et al. Transcript expression in endometrial cancers from Black and White patients
Mamelak et al. Downregulation of NDUFA1 and other oxidative phosphorylation‐related genes is a consistent feature of basal cell carcinoma
Fox et al. Altered expression of TFF-1 and CES-2 in Barrett's esophagus and associated adenocarcinomas
Suzuki et al. Aberrant methylation: common in thymic carcinomas, rare in thymomas
Stolf et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression
Callegari‐Jacques et al. Genetic variation within two linguistic Amerindian groups: Relationship to geography and population size

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1453977

Country of ref document: EP

Representative=s name: WINTER, BRANDL, FUERNISS, HUEBNER, ROESS, KAIS, DE